Cargando…
Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: A meta-analysis
BACKGROUND: Recent clinical trials have shown that adjunctive glucocorticoids is associated with inhibiting excessive inflammatory response and modulating cytokines release offering several advantages over conventional therapy on relieving clinical symptoms, reducing mortality, and improving prognos...
Autores principales: | Jiang, Shan, Liu, Tiecheng, Hu, Yuxin, Li, Ranwei, Di, Xin, Jin, Xin, Wang, Yanqiao, Wang, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616855/ https://www.ncbi.nlm.nih.gov/pubmed/31261585 http://dx.doi.org/10.1097/MD.0000000000016239 |
Ejemplares similares
-
Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis
por: Bi, Jirui, et al.
Publicado: (2016) -
Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia
por: Zhao, Bo, et al.
Publicado: (2020) -
Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia
por: Lode, H, et al.
Publicado: (2002) -
Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: A systematic review and meta-analysis
por: Huang, Jing, et al.
Publicado: (2019) -
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
por: Tanaseanu, Cristina, et al.
Publicado: (2009)